29214 Federal Register / Vol. 74, No. 117 / Friday, June 19, 2009 / Notices 

HHS Secretary’s Amendment to the 

Declaration for the Use of the Public 

Readiness and Emergency 

Preparedness Act for the Influenza 

Antivirals Oseltamivir Phosphate 

(Tamiflu®) and Zanamivir (Relenza®) 

Dated October 10, 2008 

Whereas the October 10, 2008 

declaration for Oseltamivir Phosphate 

(Tamiflu(®)) and Zanamivir (Relenza®) 

(‘‘Original Declaration’’) applies to 

administration of the aforementioned 

covered countermeasures to address the 

threat of or actual human influenza that 

results from the infection of humans 

with highly pathogenic avian influenza 

A viruses or other highly pathogenic 

influenza viruses causing a pandemic 

following exposure to the viruses; 

Whereas the current detection of 

H1N1 swine flu in Mexico and the 

United States may have the potential to 

evolve into an influenza strain capable 

of causing a pandemic of human 

influenza; 

Whereas the aforementioned covered 

countermeasures may be effective to 

protect persons from either the threat of 

H1N1 swine influenza, or to treat 

persons with H1N1 swine influenza; 

Whereas the findings made by the 

Secretary in the Original Declaration 

continue to apply generally, and apply 

with equal force as to swine influenza; 

Whereas in accordance with section 

319F–3(b)(6) of the Act (42 U.S.C. 247d– 

6d(b), I have considered the desirability 

of encouraging the design, development, 

clinical testing or investigation, 

manufacturing, labeling, distribution, 

formulation, packaging, marketing, 

promotion, sale, purchase, donation, 

dispensing, prescribing, administration, 

licensing or approval, and use of 

additional covered countermeasures 

with respect to the category of disease 

in section II of the Original Declaration, 

as amended, and have found it desirable 

to encourage such activities for these 

additional covered countermeasures, 

and; 

Whereas to encourage the design, 

development, clinical testing or 

investigation, manufacturing and 

product formulation, labeling, 

distribution, packaging, marketing, 

promotion, sale, purchase, donation, 

dispensing, prescribing, administration, 

licensing or approval, and use of 

medical countermeasures with respect 

to the category of disease described in 

section II of the Original Declaration, as 

amended, it is advisable, in accordance 

with section 319F–3(a) and (b) of the 

Act, to provide immunity from liability 

for covered persons, as that term is 

defined at section 319F–3(i)(2) of the 

Act, and to include as such covered 

persons such other qualified persons as 

I have identified in section VI of the 

Original Declaration, as amended; 

Therefore pursuant to section 319F– 

3(b) of the Act, I have determined that 

the risk that the spread of H1N1 swine 

influenza viruses and resulting disease 

constitutes a public health emergency. 

In order to clarify that the Original 

Declaration applies to H1N1 swine flu 

influenza, as well as other influenza 

strains which originate from animals 

and which have pandemic potential, the 

Original Declaration, is hereby amended 

as follows: 

Strike the current section II, ‘‘Category 

of Disease,’’ in its entirety and replace 

as follows: 

II. Category of Disease (As Required by 

Section 319F–3(b)(2)(A) of the Act) 

The category of disease, health 

condition, or threat to health for which 

I am recommending the administration 

or use of the Covered Countermeasures 

is the threat of or actual human 

influenza that results from the infection 

of humans with highly pathogenic avian 

H5N1 influenza A viruses or other 

animal influenza A viruses (including, 

but not limited to, H1N1 swine 

influenza) that are, or may be capable of 

developing into, a pandemic strain. 

In section VIII, strike the section in its 

entirety and replace it with the 

following: ‘‘This Declaration has been 

amended. The Original Declaration was 

published in the Federal Register at 73 

FR 61861. This is the first amendment 

to the Original Declaration. Any future 

amendment to this Declaration will be 

published in the Federal Register, 

pursuant to section 319F–3(b)(4) of the 

Act.’’ 

All other provisions of the Original 

Declaration remain in full force. 

This amendment to the Declaration 

will be published in the Federal 

Register, pursuant to section 319F– 

3(b)(4) of the Act. 

Dated: June 11, 2009. 

Kathleen Sebelius, 

Secretary. 

[FR Doc. E9–14412 Filed 6–18–09; 8:45 am] 

BILLING CODE 4150–37–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Toxicology Program (NTP); 

Office of Liaison, Policy and Review; 

Meeting of the Scientific Advisory 

Committee on Alternative 

Toxicological Methods (SACATM): 

Amended Notice 

AGENCY: National Institute of 

Environmental Health Sciences 

(NIEHS), National Institutes of Health 

(NIH). 

ACTION: Availability of public video 

casting of meeting. 

SUMMARY: This notice announces the 

availability of public video casting of 

the SACATM meeting on June 25–26, 

2009. The meeting will be held at the 

Hilton Arlington Hotel, 950 North 

Stafford Street, Arlington, VA 22203 

and video cast through a link on the 

SACATM Web site (http:// 

ntp.niehs.nih.gov/go/7441). Information 

regarding the meeting was announced in 

the Federal Register (74 FR 19562) 

published on April 29, 2009 and 

available on the NTP Web site (http:// 

ntp.niehs.nih.gov/go/32822). 

DATES: The SACATM meeting will be 

held on June 25 and 26, 2009. The 

meeting is scheduled from 8:30 a.m. to 

approximately 5:30 p.m. on June 25 and 

8:30 a.m. until adjournment on June 26, 

2009 

ADDRESSES: The SACATM meeting will 

be held at the Hilton Arlington Hotel, 

950 North Stafford Street, Arlington, VA 

22203 [hotel: (703) 528–6000)]. 

SUPPLEMENTARY INFORMATION: 

Archived Video of the Meeting 

Following the meeting, the archived 

video of the meeting will be available on 

the SACATM meeting Web page 

(http://ntp.niehs.nih.gov/go/7441). 

Dated: June 12, 2009. 

John R. Bucher, 

Associate Director, National Toxicology 

Program. 

[FR Doc. E9–14502 Filed 6–18–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; 

Comment Request 

Title: Evaluation of the Community 

Healthy Marriage Initiative—Impact 

Evaluation—Wave 2. 

OMB No.: 0970–0322. 

Description: The Administration for 

Children and Families (ACF), U.S. 

Department of Health and Human 

Services (HHS), is conducting a 

demonstration and evaluation called the 

Community Healthy Marriage Initiative 

(CHMI). Demonstration programs have 

been funded through Healthy Marriage 

and Responsible Fatherhood grants 

authorized under section 403(a)(2) of 

the Social Security Act to support 

healthy marriage directly and to 

mstockstill on PROD1PC66 with NOTICES

Federal Register / Vol. 74, No. 117 / Friday, June 19, 2009 / Notices 29215 

encourage community changes that 

increase support for healthy marriages 

and improve child and family 

wellbeing. 

The objective of the evaluation is to: 

(1) Assess the implementation of 

community interventions designed to 

provide marriage education by 

examining the way the projects operate 

and by examining child support 

outcomes among low-income families in 

the community; and (2) evaluate the 

community impacts of these 

interventions on marital stability and 

satisfaction, child well-being and child 

support outcomes among low income 

families. 

The purpose of this information 

collection is to conduct a follow-up 

survey of respondents from Wave 1 who 

live in the communities where CHMI 

demonstrations are operating, and a 

survey of CHMI program participants. 

The impact evaluation will assess the 

effects of community healthy marriage 

initiatives by comparing family and 

child well-being outcomes in the CHMI 

communities with similar outcomes in 

comparison communities that are well 

matched to the demonstration project 

sites. 

Respondents: Community members 

and program participants in CHMI 

treatment and comparison communities. 

ANNUAL BURDEN ESTIMATE

Instrument Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden 

hours 

per 

respondent 

Estimated 

annual burden 

hours 

Wave 2 Survey ................................................................................................ 4,120 1 .75 3,090 

Estimated Total Annual Burden 

Hours: 3,090. 

Additional Information 

Copies of the proposed collection may 

be obtained by writing to the 

Administration for Children and 

Families, Office of Planning, Research 

and Evaluation, 370 L’Enfant 

Promenade, SW., Washington, DC 

20447, Attn: OPRE Reports Clearance 

Officer. All requests should be 

identified by the title of the information 

collection. E-mail address: 

OPREinfocollection@acf.hhs.gov. 

OMB Comment 

OMB is required to make a decision 

concerning the collection of information 

between 30 and 60 days after 

publication of this document in the 

Federal Register. Therefore, a comment 

is best assured of having its full effect 

if OMB receives it within 30 days of 

publication. Written comments and 

recommendations for the proposed 

information collection should be sent 

directly to the following: Office of 

Management and Budget, Paperwork 

Reduction Project, Fax: 202–395–6974, 

Attn: Desk Officer for the 

Administration for Children and 

Families. 

Dated: June 11, 2009. 

Seth F. Chamberlain, 

OPRE Reports Clearance Officer. 

[FR Doc. E9–14181 Filed 6–18–09; 8:45 am] 

BILLING CODE 4184–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day-09–09AN] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

The Centers for Disease Control and 

Prevention (CDC) publishes a list of 

information collection requests under 

review by the Office of Management and 

Budget (OMB) in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

Chapter 35). To request a copy of these 

requests, call the CDC Reports Clearance 

Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written 

comments to CDC Desk Officer, Office of 

Management and Budget, Washington, 

DC or by fax to (202) 395–6974. Written 

comments should be received within 30 

days of this notice. 

Proposed Project 

National Youth Physical Activity and 

Nutrition Study (NYPANS)—New— 

National Center for Chronic Disease 

Prevention and Health Promotion 

(NCCDPHP), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

The prevalence of obesity among 

adolescents aged 12 to 19 more than 

tripled in the past 20 years, increasing 

from 5% in 1980 to 17.6% in 2006. 

Obese young people are more likely 

than children of normal weight to 

become overweight or obese adults, and 

are therefore more at risk for associated 

adult health problems, including heart 

disease, type 2 diabetes, stroke, several 

types of cancer, and osteoarthritis. 

However, healthy lifestyle habits, 

including healthy eating and physical 

activity, can lower the risk of becoming 

obese and developing related diseases. 

CDC proposes to conduct a study 

involving a nationally representative 

sample of students attending public and 

private schools in grades 9–12. CDC will 

collect information from students in 

Spring 2010. The primary information 

collection will include a paper-andpencil survey, a standardized protocol 

to measure height and weight, and 

telephone interviews to elicit 24-hour 

dietary recalls among a subsample of 

respondents. Information supporting the 

study also will be collected from school 

administrators and teachers. 

The study will: (1) Provide nationally 

representative data on behaviors and 

behavioral determinants related to 

physical activity and nutrition; (2) 

provide data to help improve the clarity 

and strengthen the validity of questions 

on the Youth Risk Behavior Survey 

(OMB No. 0920–0493, exp. 11/30/2011), 

which has been conducted biennially 

since 1991; and (3) improve 

understanding of the associations 

among behaviors and behavioral 

determinants related to physical activity 

and nutrition, and their association with 

body mass index. 

Study results will be used to develop 

more effective interventions for 

stemming the increase of obesity among 

adolescents, and will have implications 

for policy and program development for 

obesity prevention programs. 

There are no costs to respondents 

except their time. The total estimated 

burden hours are 7,781. 

mstockstill on PROD1PC66 with NOTICES